Eli Lilly Corp. Stock
Price
Target price
€708.10
€708.10
-0.520%
-3.7
-0.520%
€814.97
22:26 / Tradegate
WKN: 858560 / Symbol: LLY / Name: Eli Lilly / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Eli Lilly Corp. is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for Eli Lilly
sharewise wants to provide you with the best news and tools for Eli Lilly, so we directly link to the best financial data sources.
Financials
News
Eli Lilly Stock: Pipeline Success Fuels Market Dominance
Eli Lilly continues its remarkable market ascension as the pharmaceutical giant capitalizes on rival Novo Nordisk's struggles. The Indianapolis-based company has seen its weight loss medication
Eli Lilly Stock: Alzheimer Drug Advances Despite Market Caution
Eli Lilly's stock showed surprising stability, with minimal movement despite significant pipeline developments. The pharmaceutical giant received positive news as the European Medicines Agency (EMA)
Eli Lilly Stock: Biotech Acquisition Signals Growth Strategy
Eli Lilly has acquired gene therapy specialist Verve Therapeutics for $1.3 billion, marking a significant move into genetic medicine as the biotech sector emerges from a two-year slump. The